
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial - 2
Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed - 3
10 Demonstrated Systems to Develop Your Internet based Business - 4
'A perfect storm': Airlines cut flights and increase airfares as jet fuel price spikes - 5
Struggling to keep your New Year's resolutions? Here's how to keep yourself on track
Thousands of genomes reveal the wild wolf genes in most dogs’ DNA
Paul Feig loves a plot twist. Why not reboot 'Die Hard' starring a woman?
Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother
9 Under-The-Radar Malaysian Islands To Consider Instead Of Thailand Or Indonesia
Munich Security Conference chief defends inviting AfD lawmakers
What to watch for in weight loss drugs in 2026
Uncover the Manageable Fish Practices: Sea agreeable Feasting
VPN Administrations for Online Protection
Eleven Creations And Developments That Steered History













